Jushi Holdings Inc. Announces Receipt of DEA Registrations for State-Licensed Medical Cannabis Operations
Jushi Holdings Inc. (CSE: JUSH, OTCQX: JUSH) received DEA registrations for its state-licensed medical marijuana operations, following the rescheduling of medical marijuana to Schedule III. The company sees this as a milestone for alignment between state and federal regulations. Jushi is a multi-state cannabis operator focused on acquisitions and growth.
How this was made

The 30-second read
Why it matters
The DEA registrations remove a key federal barrier, likely improving access to banking and insurance, and could enhance the company's valuation as it positions for broader market participation.
Market read
First‑time federal registration for a U.S. cannabis operator; may trigger short‑term price uplift and set precedent for peers.
What to watch
Potential for future Schedule III re‑classification could alter tax treatment and banking access.
Background
Jushi Holdings Inc., a Canadian‑listed multi‑state cannabis operator, announced receipt of DEA registrations for its state‑licensed medical marijuana operations following the April 2026 order to reclassify qualifying medical cannabis to Schedule III.
Market effects
May boost sentiment for multi‑state cannabis operators awaiting federal clearance.
Positive for U.S. cannabis stocks, especially those with pending DEA applications.
Limited to U.S. cannabis sector; no broader market effect.
Counterpoint
Regulatory approval may not translate into immediate revenue if state licensing constraints persist.
Key entities
- companyJushi Holdings Inc.
Vertically integrated cannabis operator (CSE: JUSH, OTCQX: JUSH).




